Development and Optimization of Rizatriptan Benzoate-Loaded Ethosomal Thermosensitive In-Situ Nasal Gel for Brain-Targeted Migraine Therapy
Crossref DOI link: https://doi.org/10.1007/s12247-026-10522-0
Published Online: 2026-03-02
Published Print: 2026-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fernandes, Judy
Parab, Asma
Krishna, Mythili
Mali, Ashwin
Chellampillai, Bothiraja
Text and Data Mining valid from 2026-03-02
Version of Record valid from 2026-03-02
Article History
Received: 2 January 2026
Accepted: 19 February 2026
First Online: 2 March 2026
Declarations
:
: The authors declare no competing interests.